MiR-499 Regulates Cell Proliferation and Apoptosis during Late-Stage Cardiac Differentiation via Sox6 and Cyclin D1

Xianhui Li, Jiaji Wang, Zhuqing Jia, Qinghua Cui, Chenguang Zhang, Weiping Wang, Ping Chen, Kangtao Ma, Chunyan ZhouPLoS 2013 · DOI

Abstract

miR-499 probably regulates the proliferation and apoptosis of P19CL6 cells in the late stage of cardiac differentiation via its effects on Sox6 and cyclin D1.

Introduction: The Balancing Act of Heart Development

Heart development is a high-stakes balancing act. During embryonic stages, heart cells (cardiomyocytes) must proliferate rapidly to build the organ's mass—a process called hyperplasia. Shortly after birth, this division stops, and the heart grows instead by increasing the size of existing cells (hypertrophy).

While microRNAs (miRNAs) are known to be essential "dimmer switches" for gene expression during this process, the specific role of miR-499—one of the most abundant miRNAs in the heart—remained unclear. Specifically, researchers didn't fully understand how miR-499 influenced the transition between cell division and cell death during the late stages of cardiac differentiation. This study aims to map the functional pathway connecting miR-499 to its target genes to explain how it maintains the "growth engine" in developing heart cells.

Methods and Experimental Models

The researchers used a combination of in vitro cell line modeling and primary cell validation:

  • Cell Models: The primary model was the P19CL6 mouse cell line, which differentiates into beating cardiomyocytes when treated with DMSO. Findings were also validated using primary neonatal rat ventricular myocytes (NRVMs).
  • Genetic Manipulation: Stable cell lines overexpressing miR-499 (P-499 cells) were created, and antisense oligonucleotides were used to "knock down" endogenous miR-499.
  • Functional Assays: Techniques included EdU incorporation and flow cytometry for cell cycle tracking, Annexin V staining for apoptosis, and Luciferase reporter assays to confirm physical binding of miR-499 to the Sox6 gene.

Key Insights: Temporal Specificity and Molecular Brakes

A critical finding of the study is the temporal specificity of miR-499. Its expression is not constant; it spikes significantly during the late stages of differentiation (Day 8–10 in the P19CL6 model), coinciding exactly with the appearance of contractile proteins like $\beta$-MHC.

Expression of cardiac-specific markers during P19CL6 differentiation over 12 days.

Further insights include:

  • The "Hyperplastic" Signature: Overexpressing miR-499 forces late-stage cardiomyocytes to continue dividing. While normal cells exit the cell cycle at Day 10, miR-499-enriched cells maintain high rates of DNA synthesis.
  • Sox6 as the Molecular Brake: The study confirms that Sox6 acts as a brake on the cell cycle and a trigger for apoptosis. miR-499 acts as the "inhibitor of the inhibitor," silencing Sox6 to prevent this brake from being applied.
  • The Cyclin D1 Connection: Sox6 normally suppresses Cyclin D1, a driver of the cell cycle. By suppressing Sox6, miR-499 maintains higher Cyclin D1 levels, fueling continued cell division.

Key Results

  • Increased Proliferation: P-499 cells showed a 3.04-fold increase in cell viability after 48 hours compared to control cells.
  • DNA Synthesis: At Day 10 of differentiation, 42.85% of miR-499 overexpressing cells were still actively synthesizing DNA (EdU positive), compared to only ~6% in control groups.
Immunofluorescence staining showing cell morphology and marker expression in differentiated cells.
  • Apoptosis Protection: Knocking down miR-499 significantly increased cell death and the activation of Caspase-3, while overexpressing miR-499 protected cells from apoptosis.
  • Rescue Experiments: Manually overexpressing Sox6 reversed the effects of miR-499, proving that the miR-499/Sox6 axis is the primary driver of these growth effects.

Limitations and Future Work

While P19CL6 cells are a robust model, they are an immortalized cell line; the complex 3D environment of a living heart might yield different dynamics. Additionally, the authors acknowledge that miR-499’s function appears highly dependent on the specific cell type and developmental stage, as other studies have shown it can inhibit proliferation in different stem cell contexts. Future research will likely explore how other miR-499 targets interact with the Sox6/Cyclin D1 pathway to fine-tune heart growth.

Summary updated

Abstract

miR-499 probably regulates the proliferation and apoptosis of P19CL6 cells in the late stage of cardiac differentiation via its effects on Sox6 and cyclin D1.
BibTeX
@inproceedings{li2013mir,
  author = {Xianhui Li and Jiaji Wang and Zhuqing Jia and Qinghua Cui and Chenguang Zhang and Weiping Wang and Ping Chen and Kangtao Ma and Chunyan Zhou},
  title = {{MiR-499 Regulates Cell Proliferation and Apoptosis during Late-Stage Cardiac Differentiation via Sox6 and Cyclin D1}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0074504},
}
Figure